Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 44 | 2022 | 1624 | 3.870 |
Why?
|
| Radiotherapy, Intensity-Modulated | 15 | 2019 | 806 | 2.230 |
Why?
|
| Radiotherapy Dosage | 47 | 2022 | 2879 | 1.860 |
Why?
|
| Radiometry | 14 | 2018 | 800 | 1.700 |
Why?
|
| Protons | 13 | 2023 | 1127 | 1.430 |
Why?
|
| Radiotherapy, Conformal | 13 | 2015 | 548 | 1.290 |
Why?
|
| Radiation Dosage | 9 | 2018 | 1928 | 1.010 |
Why?
|
| Radiosurgery | 28 | 2013 | 1329 | 0.890 |
Why?
|
| Monte Carlo Method | 10 | 2022 | 1254 | 0.870 |
Why?
|
| Radiotherapy, High-Energy | 5 | 2007 | 228 | 0.870 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2019 | 477 | 0.730 |
Why?
|
| Uncertainty | 6 | 2019 | 735 | 0.700 |
Why?
|
| Phantoms, Imaging | 6 | 2018 | 2480 | 0.580 |
Why?
|
| Organs at Risk | 8 | 2019 | 346 | 0.560 |
Why?
|
| Algorithms | 22 | 2022 | 13882 | 0.540 |
Why?
|
| Scattering, Radiation | 9 | 2017 | 498 | 0.540 |
Why?
|
| Equipment Failure Analysis | 4 | 2010 | 868 | 0.410 |
Why?
|
| Respiration | 3 | 2007 | 1653 | 0.400 |
Why?
|
| Radiotherapy | 7 | 2007 | 1533 | 0.390 |
Why?
|
| Radiation Injuries | 10 | 2018 | 1180 | 0.380 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2010 | 67 | 0.350 |
Why?
|
| Movement | 5 | 2015 | 1471 | 0.350 |
Why?
|
| Quality Assurance, Health Care | 3 | 2018 | 2212 | 0.320 |
Why?
|
| Normal Distribution | 4 | 2019 | 280 | 0.320 |
Why?
|
| Infratentorial Neoplasms | 3 | 2018 | 94 | 0.310 |
Why?
|
| Equipment Design | 11 | 2018 | 3582 | 0.310 |
Why?
|
| Models, Theoretical | 5 | 2012 | 3589 | 0.300 |
Why?
|
| Linear Energy Transfer | 3 | 2018 | 154 | 0.280 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 340 | 0.280 |
Why?
|
| Immobilization | 2 | 2005 | 236 | 0.270 |
Why?
|
| Prostatic Neoplasms | 12 | 2019 | 11126 | 0.270 |
Why?
|
| Photons | 8 | 2018 | 588 | 0.270 |
Why?
|
| Chordoma | 2 | 2023 | 359 | 0.250 |
Why?
|
| Brachytherapy | 8 | 2003 | 1248 | 0.250 |
Why?
|
| Cyclotrons | 1 | 2004 | 30 | 0.250 |
Why?
|
| Relative Biological Effectiveness | 8 | 2018 | 323 | 0.250 |
Why?
|
| Stereotaxic Techniques | 8 | 2005 | 536 | 0.240 |
Why?
|
| Brain Stem | 4 | 2018 | 846 | 0.240 |
Why?
|
| Technology, Radiologic | 3 | 2015 | 163 | 0.230 |
Why?
|
| Brain Neoplasms | 22 | 2012 | 8861 | 0.220 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2005 | 286 | 0.220 |
Why?
|
| Calibration | 4 | 2022 | 816 | 0.210 |
Why?
|
| Biophysical Phenomena | 3 | 2015 | 327 | 0.210 |
Why?
|
| Medulloblastoma | 4 | 2017 | 683 | 0.200 |
Why?
|
| Sarcoma | 3 | 2015 | 1897 | 0.190 |
Why?
|
| Models, Statistical | 7 | 2019 | 5101 | 0.180 |
Why?
|
| Neuroma, Acoustic | 5 | 2005 | 451 | 0.180 |
Why?
|
| Radiotherapy, Computer-Assisted | 3 | 2000 | 94 | 0.180 |
Why?
|
| Astrocytoma | 4 | 2005 | 790 | 0.170 |
Why?
|
| Skull Base Neoplasms | 1 | 2023 | 284 | 0.170 |
Why?
|
| Particle Accelerators | 6 | 2007 | 173 | 0.160 |
Why?
|
| Reproducibility of Results | 9 | 2012 | 19905 | 0.160 |
Why?
|
| Neoplasms | 8 | 2015 | 21696 | 0.160 |
Why?
|
| Computer-Aided Design | 2 | 2009 | 298 | 0.150 |
Why?
|
| Microtechnology | 1 | 2017 | 70 | 0.150 |
Why?
|
| Mastectomy | 3 | 2015 | 1793 | 0.150 |
Why?
|
| Models, Biological | 4 | 2010 | 9584 | 0.140 |
Why?
|
| Humans | 90 | 2023 | 744366 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 2 | 2017 | 587 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2020 | 20130 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2015 | 876 | 0.130 |
Why?
|
| Carotid Stenosis | 1 | 2023 | 854 | 0.130 |
Why?
|
| Skull | 3 | 2023 | 814 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2005 | 4042 | 0.130 |
Why?
|
| Thoracic Wall | 2 | 2013 | 203 | 0.120 |
Why?
|
| Computer Simulation | 8 | 2010 | 6194 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2013 | 13104 | 0.120 |
Why?
|
| Probability | 1 | 2019 | 2506 | 0.110 |
Why?
|
| Radiodermatitis | 1 | 2013 | 60 | 0.110 |
Why?
|
| Models, Structural | 2 | 1993 | 361 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1431 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2019 | 35425 | 0.110 |
Why?
|
| Sensitivity and Specificity | 5 | 2009 | 14723 | 0.110 |
Why?
|
| Quality Control | 2 | 2006 | 841 | 0.100 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 258 | 0.100 |
Why?
|
| Ions | 1 | 2012 | 265 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 2736 | 0.090 |
Why?
|
| Breast Neoplasms | 7 | 2015 | 20824 | 0.090 |
Why?
|
| Leg | 1 | 2015 | 1116 | 0.090 |
Why?
|
| Biophysics | 2 | 2005 | 383 | 0.090 |
Why?
|
| Spine | 1 | 2017 | 1144 | 0.090 |
Why?
|
| Patient Care Planning | 1 | 2015 | 921 | 0.090 |
Why?
|
| Software | 4 | 2012 | 4441 | 0.090 |
Why?
|
| Carcinoma | 3 | 2015 | 2375 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1994 | 1107 | 0.080 |
Why?
|
| Cobalt Radioisotopes | 1 | 1988 | 76 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1487 | 0.080 |
Why?
|
| Ependymoma | 2 | 2017 | 334 | 0.070 |
Why?
|
| Mammaplasty | 2 | 2013 | 1204 | 0.070 |
Why?
|
| Mathematics | 3 | 1992 | 728 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 1363 | 0.070 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 2924 | 0.060 |
Why?
|
| Male | 33 | 2019 | 350115 | 0.060 |
Why?
|
| Rectum | 4 | 2003 | 904 | 0.060 |
Why?
|
| Radiography | 6 | 2013 | 7023 | 0.060 |
Why?
|
| Cavernous Sinus | 2 | 1997 | 125 | 0.060 |
Why?
|
| Restraint, Physical | 1 | 2005 | 193 | 0.060 |
Why?
|
| Time Factors | 7 | 2015 | 40075 | 0.060 |
Why?
|
| Retinoblastoma | 2 | 1998 | 317 | 0.060 |
Why?
|
| Respiratory System | 1 | 2007 | 557 | 0.060 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 841 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2011 | 1226 | 0.060 |
Why?
|
| Urethra | 2 | 2003 | 408 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2327 | 0.060 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2015 | 895 | 0.060 |
Why?
|
| Feasibility Studies | 4 | 2017 | 5077 | 0.050 |
Why?
|
| Motion | 1 | 2005 | 798 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2008 | 555 | 0.050 |
Why?
|
| Urinary Bladder | 3 | 2003 | 1173 | 0.050 |
Why?
|
| Child | 18 | 2023 | 77709 | 0.050 |
Why?
|
| Computer Systems | 3 | 2003 | 483 | 0.050 |
Why?
|
| Posture | 1 | 2005 | 958 | 0.050 |
Why?
|
| Germinoma | 1 | 2001 | 134 | 0.050 |
Why?
|
| Iodine Radioisotopes | 3 | 2000 | 1032 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
| Adolescent | 16 | 2017 | 85779 | 0.040 |
Why?
|
| Reference Standards | 1 | 2003 | 1025 | 0.040 |
Why?
|
| Optic Nerve Neoplasms | 1 | 1999 | 44 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4253 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 3508 | 0.040 |
Why?
|
| Necrosis | 2 | 2018 | 1643 | 0.040 |
Why?
|
| Texas | 1 | 2018 | 391 | 0.040 |
Why?
|
| Meningeal Neoplasms | 2 | 1997 | 1241 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 288 | 0.040 |
Why?
|
| Florida | 1 | 2018 | 435 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2017 | 2971 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2000 | 2921 | 0.040 |
Why?
|
| Child, Preschool | 11 | 2017 | 41005 | 0.040 |
Why?
|
| Glioma | 4 | 1999 | 3401 | 0.040 |
Why?
|
| Retrospective Studies | 10 | 2019 | 77460 | 0.030 |
Why?
|
| Eye Neoplasms | 1 | 1998 | 312 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 2 | 2003 | 2494 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2015 | 1771 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 1131 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 862 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 212 | 0.030 |
Why?
|
| Follow-Up Studies | 11 | 2017 | 39052 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2000 | 8949 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 402 | 0.030 |
Why?
|
| Treatment Outcome | 10 | 2015 | 63107 | 0.030 |
Why?
|
| Growth Plate | 1 | 2017 | 274 | 0.030 |
Why?
|
| Glioblastoma | 4 | 2001 | 3481 | 0.030 |
Why?
|
| Middle Aged | 22 | 2013 | 213390 | 0.030 |
Why?
|
| Teratoma | 1 | 2017 | 395 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2003 | 1890 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5223 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1997 | 271 | 0.030 |
Why?
|
| Glomus Jugulare Tumor | 1 | 1994 | 37 | 0.030 |
Why?
|
| Abducens Nerve | 1 | 1993 | 28 | 0.030 |
Why?
|
| Trochlear Nerve | 1 | 1993 | 25 | 0.030 |
Why?
|
| Ondansetron | 1 | 1994 | 90 | 0.030 |
Why?
|
| Palatal Neoplasms | 1 | 2013 | 35 | 0.030 |
Why?
|
| Adenocarcinoma | 3 | 2003 | 6364 | 0.030 |
Why?
|
| Pelvic Neoplasms | 1 | 2015 | 254 | 0.030 |
Why?
|
| Oculomotor Nerve | 1 | 1993 | 74 | 0.030 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 51 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 2015 | 268 | 0.030 |
Why?
|
| Palate, Soft | 1 | 2013 | 96 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2002 | 1377 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 1996 | 401 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1997 | 547 | 0.030 |
Why?
|
| Female | 24 | 2017 | 380193 | 0.030 |
Why?
|
| Infant | 6 | 2017 | 35134 | 0.030 |
Why?
|
| Lung | 2 | 2013 | 9857 | 0.030 |
Why?
|
| Radiation Pneumonitis | 1 | 2013 | 104 | 0.030 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 180 | 0.030 |
Why?
|
| Trigeminal Nerve | 1 | 1993 | 249 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1994 | 544 | 0.030 |
Why?
|
| Nausea | 1 | 1994 | 674 | 0.020 |
Why?
|
| Vomiting | 1 | 1994 | 637 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 1993 | 486 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2005 | 9240 | 0.020 |
Why?
|
| Meningioma | 2 | 1997 | 1209 | 0.020 |
Why?
|
| Esophagus | 1 | 2017 | 1019 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2017 | 1240 | 0.020 |
Why?
|
| Actuarial Analysis | 3 | 1999 | 378 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1993 | 554 | 0.020 |
Why?
|
| Anisotropy | 1 | 2013 | 1265 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1173 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 520 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1997 | 1062 | 0.020 |
Why?
|
| Aged | 17 | 2013 | 163288 | 0.020 |
Why?
|
| Disease-Free Survival | 3 | 2005 | 6896 | 0.020 |
Why?
|
| Benchmarking | 1 | 2015 | 1042 | 0.020 |
Why?
|
| Adult | 19 | 2013 | 214052 | 0.020 |
Why?
|
| Electrons | 1 | 1989 | 268 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2011 | 973 | 0.020 |
Why?
|
| United States | 2 | 2018 | 69872 | 0.020 |
Why?
|
| Gamma Rays | 1 | 1988 | 320 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1915 | 0.020 |
Why?
|
| Fatigue | 1 | 2013 | 1531 | 0.020 |
Why?
|
| Survival Analysis | 5 | 2001 | 10252 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2011 | 8642 | 0.020 |
Why?
|
| Cell Communication | 1 | 2012 | 1621 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 8662 | 0.020 |
Why?
|
| Reoperation | 3 | 2001 | 4201 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 1988 | 691 | 0.010 |
Why?
|
| Life Tables | 1 | 2003 | 370 | 0.010 |
Why?
|
| Age Factors | 2 | 2017 | 18373 | 0.010 |
Why?
|
| Incidence | 3 | 2017 | 20952 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1990 | 948 | 0.010 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 57776 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5882 | 0.010 |
Why?
|
| Prostate | 2 | 2002 | 1775 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 2 | 2003 | 2727 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7184 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7475 | 0.010 |
Why?
|
| Prone Position | 1 | 2002 | 194 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7282 | 0.010 |
Why?
|
| Time | 1 | 2002 | 542 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2003 | 767 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 1999 | 101 | 0.010 |
Why?
|
| Perineum | 1 | 2000 | 211 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2013 | 3749 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1999 | 6366 | 0.010 |
Why?
|
| Prospective Studies | 5 | 2005 | 53290 | 0.010 |
Why?
|
| Brain | 2 | 1995 | 26388 | 0.010 |
Why?
|
| Disease Progression | 2 | 2005 | 13286 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 15078 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1998 | 388 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23336 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2001 | 501 | 0.010 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 1997 | 102 | 0.010 |
Why?
|
| Pituitary Neoplasms | 2 | 1996 | 1345 | 0.010 |
Why?
|
| Skull Neoplasms | 1 | 1997 | 173 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16690 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3616 | 0.010 |
Why?
|
| Prochlorperazine | 1 | 1994 | 17 | 0.010 |
Why?
|
| Radiation Protection | 1 | 1998 | 419 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2000 | 11031 | 0.010 |
Why?
|
| Pons | 1 | 1995 | 245 | 0.010 |
Why?
|
| Cranial Nerve Diseases | 1 | 1993 | 112 | 0.010 |
Why?
|
| Survival Rate | 2 | 1999 | 12788 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 1996 | 281 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1998 | 1285 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 29060 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 1995 | 460 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1999 | 12244 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56429 | 0.010 |
Why?
|
| Alopecia | 1 | 1994 | 382 | 0.010 |
Why?
|
| Artifacts | 1 | 1999 | 1904 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 12356 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1995 | 2618 | 0.010 |
Why?
|
| Cerebellum | 1 | 1995 | 1488 | 0.000 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1995 | 1534 | 0.000 |
Why?
|
| Retina | 1 | 1998 | 2616 | 0.000 |
Why?
|
| Patient Selection | 1 | 1998 | 4216 | 0.000 |
Why?
|
| Adenoma | 1 | 1996 | 2174 | 0.000 |
Why?
|
| Boston | 1 | 1998 | 9312 | 0.000 |
Why?
|
| Remission Induction | 1 | 1990 | 2385 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 13991 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1994 | 8319 | 0.000 |
Why?
|
| Quality of Life | 1 | 1999 | 12802 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1995 | 15297 | 0.000 |
Why?
|
| Melanoma | 1 | 1990 | 5511 | 0.000 |
Why?
|
| Risk Factors | 1 | 1990 | 72296 | 0.000 |
Why?
|
Concepts
(256)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_